Events

Venue: London

The workshop will provide a neutral platform for regulators and industry to jointly review experience from pharmacovigilance audits and inspections across national boundaries, and increase the common understanding of the role of pharmacovigilance inspections and improve future collaboration.

KEY TOPICS

Audit and inspection findings related to:

Venue: Hilton Birmingham Metropole Hotel, Birmingham

Abstract submission is invited for oral and poster presentations during the congress. Following the success from last year's HRC, the extended programme of two Oral Abstract sessions and two Moderated Poster sessions has been kept. A new Featured Poster session is planned for the first day where top-scoring posters will be presented over a drinks reception. Standard poster presentations will continue throughout the conference.

The Young Investigators Competition remains a prominent feature in the congress, where up to 6 finalists will present their abstracts in oral form. To engage audience participation, there will be a public vote during the competition (in 'Y' factor style) which will count towards the total score where the final decision will be made by the judges panel. Entry into this high-profile competition is encouraged in the abstract submission. The work should be original research undertaken by the presenter who is normally trainee during the research period. Audit, database and retrospective data on clinical practice are not expected to fall within this category.

This conference is jointly organised between the Human Genome Organisation (HUGO) and the International Association of Breast Cancer Research (IABCR) and focuses on the intersection of Genomics , Biology, and Breast Cancer Treatment.

This conference aims to be relevant to clinicians and researchers who wish to explore the extension of their work into this translational interface. It will include educational sessions to expose basic scientists to clinical breast cancer treatment, and clinicians to fundamental breast cancer research.

Location: Biopolis, Singapore

Venue: Brussels

For decades, progress in neonatology, obstetrics and perinatology led to major reductions in fetal, newborn and maternal morbidity and mortality.

The next step in improving maternal and newborn health with measurable results is to focus on the time just before or around conception. 
That's the purpose of preconception care !

The goal of an international meeting on preconception care is to promote preconception visit as a part of the first line care. It is also to increase people's awareness (users, medical providers, political decision makers...) of the salience of a structured preconception consultation.

ONE (Birth and Childhood office, French-speaking part of Belgium) strives to meet the targets of child protection, child welfare and maternal protection. Therefore the Office has a substantial role in achieving these goals and can be considered a natural leader for this European congress.

The GGOLFB (Belgian Association of French speaking Gynaecologists and Obstetricians), greatly aware of ethical debates about preconception care, has agreed to integrate its annual meeting about ethical problems in Gynecology and Obstetrics into this congress.

Congress objectives :

An event to launch a new report from the Nuffield Council on Bioethics.

Following a two-year inquiry, the UK’s Nuffield Council on Bioethics will publish a report that examines the ethical issues around new developments in medical profiling and online medicine, and makes recommendations for policy and practice.

Chair: Dr Geoff Watts. Speakers: Christopher Hood, Nikolas Rose, Jonathan Wolff, Peter C Smith

Venue: The Law Society, 113 Chancery Lane, London, WC2A 1PL

Location: Queens Hotel, Leeds

Venue: Central London

Venue: RSM, London

Venue: Royal College of Pathologists, 2 Carlton House Terrace, London, SW1Y 5AF

The cardiac charity SADS UK is holding their Heart to Heart Conference to educate and inspire attendees who may come into contact with families and individuals living with inherited cardiac conditions or who may have been affected by a Sudden Arrhythmic Death (SAD).

The many facets of how people can be identified and treated will be discussed by cardiologists and professionals in emergency care.  Heart monitoring to identify abnormal heart rhythms and defibrillators in the community will be discussed.

Location: Wellcome Trust Genome Campus, Hinxton, Cambridge, UK